Stay updated with breaking news from Avoid Hepatoxicity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AGEN2373 is the first CD137 agonist antibody reporting single agent responses with no major toxicity Responses reported in patients with prostate cancer, ampullary carcinoma and metastatic vulvar... | June 5, 2023
– Data Across 30 Abstracts Reinforce Leadership in Metastatic Breast Cancer and Demonstrate Breadth of Pipeline Across Lung, Hematologic, Genitourinary, Gastrointestinal, Gynecological and... | May 17, 2023
AGENUS INC. : News, information and stories for AGENUS INC. | Nasdaq: AGEN | Nasdaq